News Positive results announced for ViiV Healthcare's two-drug HI... A two-drug strategy has shown positive results, giving new hope to patients with HIV.
News ViiV's HIV drug could be used for TB co-infection patients Interim results suggest new treatment option for patients with TB and HIV
News ViiV to begin trials of HIV prevention injection GSK hopes patients will prefer PrEP injection to pills.
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
